A detailed history of Russell Investments Group, Ltd. transactions in Castle Biosciences Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 31,693 shares of CSTL stock, worth $689,956. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,693
Previous 31,983 0.91%
Holding current value
$689,956
Previous $690,000 1.59%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$18.06 - $25.3 $5,237 - $7,337
-290 Reduced 0.91%
31,693 $701,000
Q4 2023

Feb 05, 2024

BUY
$12.19 - $22.43 $36,545 - $67,245
2,998 Added 10.34%
31,983 $690,000
Q3 2023

Nov 13, 2023

BUY
$13.28 - $20.3 $282,399 - $431,679
21,265 Added 275.45%
28,985 $489,000
Q2 2023

Aug 10, 2023

BUY
$11.66 - $26.0 $90,015 - $200,720
7,720 New
7,720 $105,000
Q3 2022

Nov 04, 2022

BUY
$22.51 - $34.32 $1.95 Million - $2.97 Million
86,551 New
86,551 $2.26 Million
Q4 2021

Jan 21, 2022

SELL
$39.06 - $67.58 $3.47 Million - $6 Million
-88,774 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$60.13 - $77.6 $654,034 - $844,055
10,877 Added 13.96%
88,774 $5.9 Million
Q2 2021

Aug 04, 2021

SELL
$50.07 - $76.78 $105,847 - $162,312
-2,114 Reduced 2.64%
77,897 $5.71 Million
Q1 2021

May 10, 2021

SELL
$58.92 - $97.33 $1.79 Million - $2.96 Million
-30,374 Reduced 27.52%
80,011 $5.48 Million
Q4 2020

Feb 08, 2021

BUY
$43.6 - $73.05 $62,609 - $104,899
1,436 Added 1.32%
110,385 $7.41 Million
Q3 2020

Nov 09, 2020

BUY
$38.47 - $52.03 $715,349 - $967,497
18,595 Added 20.58%
108,949 $5.6 Million
Q2 2020

Aug 05, 2020

BUY
$27.28 - $43.01 $381,538 - $601,537
13,986 Added 18.31%
90,354 $3.4 Million
Q1 2020

May 06, 2020

BUY
$23.08 - $35.53 $524,954 - $808,129
22,745 Added 42.42%
76,368 $2.27 Million
Q4 2019

Jan 29, 2020

BUY
$15.74 - $35.04 $571,440 - $1.27 Million
36,305 Added 209.64%
53,623 $1.84 Million
Q3 2019

Nov 01, 2019

BUY
$18.09 - $27.92 $313,282 - $483,518
17,318 New
17,318 $313,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $572M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.